The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...
The biotech also raised $235 million in debt and equity funding to support marketing of the drop, which it claims to be an ...
MedPage Today on MSN
FDA OKs More Eye Drops That Can Replace Reading Glasses
Once-daily carbachol/brimonidine tartrate significantly improves aging-related vision loss ...
YUVEZZI (TM) (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is a dual-agent eye drop approved by the U.S. Food & Drug Administration (FDA) for the treatment of presbyopia, a ...
Tenpoint Therapeutics’ Yuvezzi gets US FDA nod; the first and only combo eye drop approved to treat presbyopia: London Saturday, January 31, 2026, 14:00 Hrs [IST] Tenpoint Thera ...
(Gray News) - Several eye care products used to treat dry and irritated eyes are being voluntarily recalled. According to AvKARE, a pharmaceutical manufacturer, it has issued a recall following an ...
Tens of thousands of cases of eye drops have been recalled by BRS Analytical Services. The recall was initiated on April 23, but the Food and Drug Administration listed it as a Class II on May 6, ...
Credit: Alcon. Access initiatives including a First Fill Free trial program and an ongoing copay support will be available for eligible patients. The active ingredient in Tryptyr is acoltremon, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results